{
  "meta": {
    "title": "14_Anti-Arrythmic_Drugs",
    "url": "https://brainandscalpel.vercel.app/14-anti-arrythmic-drugs-3a522d37.html",
    "scrapedAt": "2025-11-30T12:34:07.885Z"
  },
  "questions": [
    {
      "text": "A patient diagnosed with ventricular tachycardia was started on a class1B anti-arrhythmic drug. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Mexiletine"
        },
        {
          "id": 2,
          "text": "Quinidine"
        },
        {
          "id": 3,
          "text": "Flecainide"
        },
        {
          "id": 4,
          "text": "Propafenone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Mexiletine </strong>is a&nbsp;<strong>class 1B antiarrhythmic</strong> drug.<strong>&nbsp;</strong>It<strong>&nbsp;</strong>is a lidocaine analog.</p><hr><h3>Related Pearl: Anti-arrhythmic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>&beta;- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1905",
      "difficulty": "medium"
    },
    {
      "text": "The additional mechanism by which class 1A drugs additionally prolong action potential duration is:",
      "choices": [
        {
          "id": 1,
          "text": "Blocking Na+ channels"
        },
        {
          "id": 2,
          "text": "Opening Na+ channels"
        },
        {
          "id": 3,
          "text": "Blocking K+ channels"
        },
        {
          "id": 4,
          "text": "Opening K+ channels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Class IA </strong>antiarrhythmics&nbsp;<strong>block K+ channels&nbsp;</strong>leading to&nbsp;<strong>prolong</strong>ation of <strong>action potential</strong> duration.</p>\n<p>The <strong>main</strong> action of class IA antiarrhythmics is&nbsp;<strong>blocking Na <sup>+&nbsp;</sup>channels </strong>causing:&nbsp;</p>\n<ul>\n<li>Slowing the upstroke of the action potential</li>\n<li>Slowing conduction</li>\n<li>Prolonging the QRS duration</li>\n</ul><hr><h3>Related Pearl: Anti-arrhythmic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>&beta;- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1906",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following antiarrhythmics has the fastest rate of recovery on Na+ channel blockade?<div class='question-desc-html'><ol>\n<li>Procainamide</li>\n<li>Phenytoin</li>\n<li>Flecainide</li>\n<li>Mexiletine</li>\n<li>Propafenone</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3 and 5"
        },
        {
          "id": 2,
          "text": "2 and 4"
        },
        {
          "id": 3,
          "text": "4 and 5"
        },
        {
          "id": 4,
          "text": "2 only"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Phenytoin</strong> and <strong>mexiletine</strong>&nbsp;which are class IB antiarrhythmic drugs have the <strong>fastest rate</strong> of <strong>recovery</strong> on<strong>&nbsp;Na+ channel blockade</strong>.</p>\n<p>They<strong>&nbsp;</strong>show&nbsp;the <strong>fastest&nbsp;dissociation </strong>kinetics to<strong>&nbsp;Na+ channel blockade&nbsp;</strong>(&lt;1 sec).</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Na<sup>+ </sup>channel blockade</strong></p>\n</td>\n<td>\n<p><strong>Potassium channel </strong></p>\n</td>\n<td>\n<p><strong>Action potential duration</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Class IA</strong></p>\n</td>\n<td>\n<p>Intermediate- 1-10 sec</p>\n</td>\n<td>\n<p>Significant K<sup>+</sup> channel blocker</p>\n</td>\n<td>\n<p>Prolonged</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Class IB</strong></p>\n</td>\n<td>\n<p>Rapid- &lt;1 sec</p>\n</td>\n<td>\n<p>K<sup>+</sup> channel opener</p>\n</td>\n<td>\n<p>Shortened or no effect</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Class IC</strong></p>\n</td>\n<td>\n<p>Slow- &gt;10 sec</p>\n</td>\n<td>\n<p>Negligible K<sup>+</sup> channel blocker</p>\n</td>\n<td>\n<p>Variable or no effect</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/514a78a442434412aaa593c0eee1fa8bx1280x2735.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1913",
      "difficulty": "medium"
    },
    {
      "text": "Dofetilide belongs to which class of anti-arrhythmic drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Class I"
        },
        {
          "id": 2,
          "text": "Class II"
        },
        {
          "id": 3,
          "text": "Class III"
        },
        {
          "id": 4,
          "text": "Class IV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Dofetilide</strong> belongs to <strong>class III</strong> of anti-arrhythmic drugs.</p><hr><h3>Related Pearl: Anti-arrhythmic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>&beta;- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8487",
      "difficulty": "medium"
    },
    {
      "text": "An athlete diagnosed with atrial fibrillation was administered an antiarrhythmic drug.  Several hours later, he complains of lower abdominal pain and not having passed urine since admission. Examination reveals a palpable bladder. Which was the most probable drug administered?",
      "choices": [
        {
          "id": 1,
          "text": "Quinidine"
        },
        {
          "id": 2,
          "text": "Disopyramide"
        },
        {
          "id": 3,
          "text": "Procainamide"
        },
        {
          "id": 4,
          "text": "Quinine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario is suggestive of <strong>urinary retention. Disopyramide,&nbsp;</strong>a&nbsp;class 1A antiarrhythmic<strong>&nbsp;</strong>is the drug most likely to cause these symptoms in this patient.</p>\n<p>It causes prominent <strong>anticholinergic side effects</strong> like urinary retention, dry mouth, blurred vision, precipitation of glaucoma, and constipation.&nbsp;</p>\n<p>It is the drug of choice for <strong>vagal</strong>ly mediated<strong> atrial fibrillation</strong> such as sleep-induced or atrial fibrillation in athletes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1929",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is associated with QT prolongation?",
      "choices": [
        {
          "id": 1,
          "text": "Lignocaine"
        },
        {
          "id": 2,
          "text": "Quinidine"
        },
        {
          "id": 3,
          "text": "Magnesium sulfate"
        },
        {
          "id": 4,
          "text": "All of the above"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>QT prolongation</strong> is seen with<strong>&nbsp;quinidine.&nbsp;</strong></p>\n<p>It causes torsades de pointes, a&nbsp;life-threatening form of&nbsp;<strong>polymorphic ventricular tachycardia.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6538f64b996042a2988f62f01335e095x1268x324.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Drugs causing QT prolongation and torsades de pointes</h3><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br />&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3721",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with sinus bradycardia and bronchospasm. She was previously diagnosed with AV nodal reentrant tachycardia and had been started on an antiarrhythmic drug. Which of the following drugs is most likely being used?",
      "choices": [
        {
          "id": 1,
          "text": "Flecainide"
        },
        {
          "id": 2,
          "text": "Propafenone"
        },
        {
          "id": 3,
          "text": "Mexiletine"
        },
        {
          "id": 4,
          "text": "Lidocaine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Propafenone </strong>is the most likely drug being used in this patient as <strong>sinus bradycardia</strong> and <strong>bronchospasm</strong> are <strong>adverse effects</strong> seen with the use of this drug.</p>\n<p>These side effects are due to its <strong>weak beta-blocking</strong> activity.<strong>&nbsp;</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2003",
      "difficulty": "medium"
    },
    {
      "text": "Blurred vision in a patient being treated for paroxysmal supraventricular tachycardia is most likely due to:",
      "choices": [
        {
          "id": 1,
          "text": "Esmolol"
        },
        {
          "id": 2,
          "text": "Dronedarone"
        },
        {
          "id": 3,
          "text": "Dofetilide"
        },
        {
          "id": 4,
          "text": "Flecainide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Blurred vision</strong> is the <strong>most common</strong> dose-related <strong>non-cardiac adverse effect</strong> of<strong> flecainide</strong> therapy.&nbsp;</p>\n<p>Flecainide is a <strong>class 1C antiarrhythmic</strong> agent. It acts mainly by sodium channel blockade. It does not cause any change in the action potential duration.&nbsp;</p>\n<p>Flecainide is used in paroxysmal supraventricular tachycardia (<strong>PSVTs</strong>):&nbsp;</p>\n<ul>\n<li>Atrioventricular nodal re-entrant tachycardia (<strong>AVNRT</strong>)</li>\n<li>AV re-entrant tachycardia (<strong>AVRT</strong>)</li>\n<li>Atrial fibrillation/atrial flutter (without structural heart disease)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3114",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following antiarrhythmics has both class II and class III action?",
      "choices": [
        {
          "id": 1,
          "text": "Propranolol"
        },
        {
          "id": 2,
          "text": "Esmolol"
        },
        {
          "id": 3,
          "text": "Sotalol"
        },
        {
          "id": 4,
          "text": "Nadolol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Sotalol</strong> is a <strong>class III </strong>antiarrhythmic agent with <strong>additional beta-adrenergic blocking</strong> effects. (class II antiarrhythmic action)</p>\n<p>Propranolol is a class II antiarrhythmic agent that has an additional Na<sup>+</sup> channel blocking effect. (class I antiarrhythmic action)</p>\n<p>Esmolol is a short-acting beta-blocker with minimal/no action on cardiac Na<sup>+ </sup>and K<sup>+</sup> channels.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1918",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented to the ER with dizziness and palpitations. ECG is shown below. Which of the following drugs cannot be used in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Digoxin"
        },
        {
          "id": 2,
          "text": "Verapamil"
        },
        {
          "id": 3,
          "text": "Quinidine"
        },
        {
          "id": 4,
          "text": "Lignocaine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The scenario and ECG findings (<strong>absent P waves</strong> and <strong>RR intervals</strong> that are <strong>irregularly irregular)</strong> are suggestive of <strong>atrial fibrillation. Lignocaine</strong> is not used in atrial arrhythmias. </p>\n<p><strong>Lignocaine</strong> is a <strong>class</strong> <strong>1B anti-arrhythmic agent.</strong> It <strong>blocks Na+</strong> channels mostly in the <strong>closed/inactivated state</strong>. It is not used in atrial arrhythmias because the atrial action potential is so short that the Na+ channels are in a closed/ inactivated state for only a brief amount of time.</p>\n<p>Lignocaine is used in the acute treatment of<strong> ventricular tachycardia</strong> and <strong>ventricular fibrillation.</strong></p>\n<div class=\"O0\">Drugs mostly used for <strong>supraventricular</strong> arrhythmia are:</div>\n<ul>\n<li class=\"O1\">Adenosine</li>\n<li class=\"O1\"><strong>Verapamil</strong></li>\n<li class=\"O1\">Diltiazem</li>\n<li class=\"O1\"><strong>Digoxin</strong></li>\n</ul>\n<div class=\"O1\">Drugs used for <strong>ventricular</strong> arrhythmia are:</div>\n<ul>\n<li class=\"O1\">Lidocaine </li>\n<li class=\"O1\">Mexiletine</li>\n</ul>\n<div class=\"O1\">Drugs used in <strong>both</strong> conditions are:</div>\n<ul>\n<li class=\"O1\">Amiodarone</li>\n<li class=\"O1\">Beta-blockers</li>\n<li class=\"O1\">Class 1a / 1c antiarrhythmics</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/910b818d2ef64c448a6bb019951055d6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1930",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is incorrect regarding lignocaine?",
      "choices": [
        {
          "id": 1,
          "text": "Gastrointestinal absorption is good"
        },
        {
          "id": 2,
          "text": "High volume of distribution"
        },
        {
          "id": 3,
          "text": "In heart failure patients, both loading and maintenance doses are decreased"
        },
        {
          "id": 4,
          "text": "Indicated for prophylaxis of arryhythmias in all cases of suspected MI"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Lignocaine decreases</strong> the incidence of <strong>arrhythmias</strong> in patients with<strong> suspected MI. </strong>However, it&nbsp;<strong>increases mortality</strong> probably by precipitating <strong>heart block</strong> or <strong>congestive</strong> <strong>heart failure.</strong> Hence it is <strong>not</strong> routinely used&nbsp;for <strong>prophylaxis</strong> in MI patients&nbsp;but it is used only when indicated.</p>\n<p>Gastrointestinal absorption of lignocaine is good but bioavailability is very less due to <strong>high first-pass hepatic metabolism</strong>. Therefore, it is not used through the oral route.&nbsp;</p>\n<p>Lignocaine has a <strong>high volume of distribution</strong>. The loading dose is required to achieve rapid action.&nbsp;</p>\n<p>In heart failure, both volumes of distribution and clearance are reduced. Both the loading dose and maintenance dose have to be reduced.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1984",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a correct statement regarding antiarrhythmics?",
      "choices": [
        {
          "id": 1,
          "text": "Sotalol has additional class II action"
        },
        {
          "id": 2,
          "text": "Esmolol has additional class IV action"
        },
        {
          "id": 3,
          "text": "Propranolol has additional class I action"
        },
        {
          "id": 4,
          "text": "Both A and C"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sotalol</strong> has<strong> both class II</strong> (beta-blocker) <strong>and class III action</strong> (K+ channel blockade). Though it is a nonselective beta-blocker, as an antiarrhythmic, it is classified under class III.&nbsp;</p>\n<p>Propranolol is a non-selective beta-blocker with additional membrane-stabilizing action especially at higher doses: Na+ channel blockade/ class I action.</p>\n<p>Esmolol is a beta 1 selective blocker that does not have any additional class effect.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1991",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presents to the OPD with complaints of bluish discoloration of the skin on the sun-exposed areas. He has been on medication for monomorphic ventricular tachycardia for the past 3 years. Which drug is most likely implicated in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Lidocaine"
        },
        {
          "id": 2,
          "text": "Adenosine"
        },
        {
          "id": 3,
          "text": "Amiodarone"
        },
        {
          "id": 4,
          "text": "Mexiletine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The scenario is suggestive of&nbsp;<strong>blue man syndrome </strong>which<strong>&nbsp;</strong>is most likely caused by&nbsp;<strong>amiodarone.</strong></p>\n<p>One of the side effects of amiodarone is <strong>photosensitivity</strong>.<strong>&nbsp;</strong>In some cases, bluish discoloration of the skin is seen, predominantly in the sun-exposed areas. This could be due to the <strong>immune response in dermal layers</strong> by amiodarone or the accumulation of amiodarone in superficial layers of skin.</p>\n<p>The symptoms are <strong>reversible</strong> on drug discontinuation. The syndrome is related to both dose and photosensitivity.</p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li>Corneal microdeposits</li>\n<li>Hepatotoxicity</li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>\n<p>Other such syndromes associated with drugs are:</p>\n<ul>\n<li>Red man syndrome - Vancomycin</li>\n<li>Gray baby syndrome -&nbsp;Chloramphenicol</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1994",
      "difficulty": "easy"
    },
    {
      "text": "Chronic usage of an antiarrhythmic drug leads to optic neuritis and smurf skin or ceruloderma in a patient. Which of the following is not a mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "K+ and Na+ channel blockade"
        },
        {
          "id": 2,
          "text": "Ca2+ channel blockade"
        },
        {
          "id": 3,
          "text": "Adrenergic blockade"
        },
        {
          "id": 4,
          "text": "Cl- channel blockade"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Optic neuritis and smurf skin (blueman syndrome or ceruloderma) are caused by<strong> amiodarone.&nbsp;</strong>It<strong>&nbsp;</strong>acts by <strong>blocking K<sup>+</sup>, Na</strong><sup>+,&nbsp;</sup>and&nbsp;<strong>Ca<sup>2+</sup> channels. </strong>It also <strong>blocks&nbsp;adrenergic effects.&nbsp;</strong>It does not block Cl<sup>-</sup> channels.</p>\n<p>Amiodarone is classified as a <strong>class III</strong> antiarrhythmic agent. It exerts its function through the following mechanisms:</p>\n<ul>\n<li>Blockade of transient outward delayed rectifier and inward rectifier K<sup>+</sup> currents</li>\n<li>Blockade of inactivated Na<sup>+</sup> channels with a rapid rate of recovery</li>\n<li>Decreases Ca<sup>2+</sup> current</li>\n<li>Non-competitive adrenergic blockade</li>\n</ul>\n<p>It is the drug of choice for <strong>acute</strong> treatment of <strong>VT</strong> and <strong>VF.</strong></p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li>Corneal microdeposits</li>\n<li>Hepatotoxicity</li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1995",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following adverse effects is least likely in a patient who is on chronic amiodarone therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Dry cough"
        },
        {
          "id": 2,
          "text": "Corneal microdeposits"
        },
        {
          "id": 3,
          "text": "Hepatic dysfunction"
        },
        {
          "id": 4,
          "text": "Nephrotoxicity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Nephrotoxicity is not an adverse effect of&nbsp;chronic amiodarone therapy.&nbsp;<strong>Pulmonary fibrosis</strong>&nbsp;associated with <strong>dry cough</strong> is the most serious side effect of<strong> chronic amiodarone therapy</strong>. It can rapidly progress and become fatal.</p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li><strong>Corneal microdeposits</strong></li>\n<li><strong>Hepatotoxicity</strong></li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1999",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following antiarrhythmic drugs is contraindicated in a patient with interstitial lung disease?",
      "choices": [
        {
          "id": 1,
          "text": "Amiodarone"
        },
        {
          "id": 2,
          "text": "Sotalol"
        },
        {
          "id": 3,
          "text": "Quinidine"
        },
        {
          "id": 4,
          "text": "Lignocaine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Amiodarone</strong> is&nbsp;<strong>contraindicated</strong> in a patient with <strong>interstitial lung disease.</strong></p>\n<p>The most serious<strong> adverse effect</strong> during chronic amiodarone therapy is <strong>pulmonary fibrosis</strong>, which can be rapidly progressive and fatal. <strong>Underlying lung disease</strong>, doses of 400 mg/day or more, and recent pulmonary insults such as pneumonia appear to be <strong>risk factors</strong> for this condition.</p>\n<p>Amiodarone is a class III antiarrhythmic drug.</p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li>Corneal microdeposits</li>\n<li>Hepatotoxicity</li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0777",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about dronedarone is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "It does not contain iodine moiety"
        },
        {
          "id": 2,
          "text": "Has stronger antiadrenergic effects than amiodarone"
        },
        {
          "id": 3,
          "text": "Less effective antiarrhythmic when compared to amiodarone"
        },
        {
          "id": 4,
          "text": "Dose adjustment has to be done in renal failure"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Dronedarone</strong> undergoes <strong>hepatic metabolism</strong> and hence dose <strong>adjustment</strong>&nbsp;is <strong>not required</strong> in <strong>renal failure</strong> as it is not excreted through the kidneys.</p>\n<p>Dronedarone is a <strong>non-iodinated</strong> congener of amiodarone. Like amiodarone, it is a blocker of multiple ion channels. It has <strong>stronger antiadrenergic</strong> <strong>effects</strong> than amiodarone. It is <strong>less effective</strong> in maintaining sinus rhythm and is considered less antiarrhythmic when compared to amiodarone.&nbsp;</p>\n<p>Unlike amiodarone, it does not cause thyroid dysfunction or pulmonary fibrosis. However, it causes <strong>hepatotoxicity</strong> and increases the risk of stroke and heart failure.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3101",
      "difficulty": "hard"
    },
    {
      "text": "Given below is the ECG of a patient who presented to the emergency room with sudden onset palpitations and breathlessness. Which of the following drugs can be used in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Atropine"
        },
        {
          "id": 2,
          "text": "Mexiletine"
        },
        {
          "id": 3,
          "text": "Verapamil"
        },
        {
          "id": 4,
          "text": "Lidocaine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario and the ECG findings are suggestive of&nbsp;<strong>paroxysmal supraventricular tachycardia</strong> (PSVT). <strong>Verapamil</strong> and <strong>diltiazem</strong> are used in both <strong>acute treatment</strong> and <strong>prophylaxis</strong> of PSVT.</p>\n<p>Their mechanism of action is by <strong>slowing SA node </strong>automaticity and<strong> AV nodal conduction velocity</strong>. Additionally, they also decrease cardiac contractility and reduce blood pressure.</p>\n<p>Dihydropyridines like nifedipine and amlodipine do not have any antiarrhythmic property.</p>\n<div class=\"O0\">Drugs used for <strong>supraventricular</strong> arrhythmias are:</div>\n<ul>\n<li class=\"O1\">Adenosine</li>\n<li class=\"O1\">Verapamil</li>\n<li class=\"O1\">Diltiazem</li>\n<li class=\"O1\">Digoxin</li>\n</ul>\n<div class=\"O1\">Drugs used for <strong>ventricular</strong> arrhythmias are:</div>\n<ul>\n<li class=\"O1\">Lidocaine&nbsp;</li>\n<li class=\"O1\">Mexiletine</li>\n</ul>\n<div class=\"O1\">Drugs used in <strong>both</strong> conditions are:</div>\n<ul>\n<li class=\"O1\">Amiodarone</li>\n<li class=\"O1\">Beta-blockers</li>\n<li class=\"O1\">Class 1A / 1C antiarrhythmics</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/16c4534451f244bf9c43d74c07268356x510x812.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b062624679194d43acf969ad9e87358a.GIF"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3104",
      "difficulty": "medium"
    },
    {
      "text": "Vernakalant is indicated in which of the following types of arrhythmias?",
      "choices": [
        {
          "id": 1,
          "text": "Ventricular fibrillation"
        },
        {
          "id": 2,
          "text": "Atrial fibrillation"
        },
        {
          "id": 3,
          "text": "Atrial flutter"
        },
        {
          "id": 4,
          "text": "Ventricular flutter"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Vernakalant</strong> is&nbsp;a newer antiarrhythmic agent indicated in <strong>atrial fibrillation</strong>.</p>\n<p>Its mechanisms of action include:</p>\n<ul>\n<li>Frequency and voltage-dependent <strong>block</strong> of the early and late components of the <strong>sodium</strong> current</li>\n<li>The muscarinic <strong>potassium</strong> current <strong>I<sub>KACh</sub>,</strong> which is constitutively activated in atrial fibrillation is also <strong>blocked</strong></li>\n</ul>\n<p>It is indicated for <strong>rapid termination</strong> of atrial fibrillation in patients with no or minimal structural heart disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3111",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with palpitations and light-headedness. His ECG is shown below. Which of the following drugs is least likely to cause this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Quinidine"
        },
        {
          "id": 2,
          "text": "Disopyramide"
        },
        {
          "id": 3,
          "text": "Procainamide"
        },
        {
          "id": 4,
          "text": "Lidocaine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario and the ECG findings (<strong>rapid asynchronous complexes</strong> and an <strong>undulating</strong> <strong>baseline</strong>) point towards a diagnosis of <strong>torsades de pointes.</strong> <strong>Lidocaine</strong> use is unlikely to cause this condition.</p>\n<p><strong>Lidocaine</strong> belongs to class IB antiarrhythmics. It is considered to have the <strong>least arrhythmogenic</strong> potential among antiarrhythmics.</p>\n<p>Among the antiarrhythmics, <strong>class Ia</strong> and <strong>class III</strong> drugs prolong action potential duration and thus <strong>prolong QT interval.</strong> They are also prone to cause torsades de pointes.</p><hr><h3>Related Pearl: Drugs causing QT prolongation and torsades de pointes</h3><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br />&nbsp;</li>\n</ul><hr><h3>Related Pearl: Anti-arrhythmic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>&beta;- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/00e9fd31a507460192d5b3caf8c74708.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3109",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the drug of choice for the immediate management of a patient with paroxysmal supraventricular tachycardia?",
      "choices": [
        {
          "id": 1,
          "text": "Verapamil"
        },
        {
          "id": 2,
          "text": "Diltiazem"
        },
        {
          "id": 3,
          "text": "Digoxin"
        },
        {
          "id": 4,
          "text": "Adenosine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The drug of choice for the termination of <strong>PSVT</strong> is <strong>adenosine.</strong><strong>&nbsp;</strong></p>\n<div class=\"O0\">Drugs used for <strong>supraventricular</strong> arrhythmias are:</div>\n<ul>\n<li class=\"O1\">Adenosine</li>\n<li class=\"O1\">Verapamil</li>\n<li class=\"O1\">Diltiazem</li>\n<li class=\"O1\">Digoxin</li>\n</ul>\n<div class=\"O1\">Drugs used for <strong>ventricular</strong> arrhythmias are:</div>\n<ul>\n<li class=\"O1\">Lidocaine&nbsp;</li>\n<li class=\"O1\">Mexiletine</li>\n</ul>\n<div class=\"O1\">Drugs used in <strong>both</strong> conditions are:</div>\n<ul>\n<li class=\"O1\">Amiodarone</li>\n<li class=\"O1\">Beta-blockers</li>\n<li class=\"O1\">Class 1a / 1c antiarrhythmics</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/710e0226cb07491b9ae0ac0c7d3d64f3x510x812.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3106",
      "difficulty": "easy"
    },
    {
      "text": "A patient who was recently diagnosed with a seizure disorder presents to the casualty with altered mental status. His ECG shows a prolonged QTc. There is history of sudden cardiac deaths in his family at an early age.  On further evaluation, a diagnosis of congenital long QT syndrome is made. Which is the most suitable pharmacological agent to treat this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Metoprolol"
        },
        {
          "id": 2,
          "text": "Mexilitine"
        },
        {
          "id": 3,
          "text": "Nicorandil"
        },
        {
          "id": 4,
          "text": "Isoprenaline"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Beta-blockers</strong> like metoprolol are the mainstay of <strong>pharmacological</strong> therapy in both <strong>asymptomatic</strong> and <strong>symptomatic</strong> patients with <strong>congenital LQTS.&nbsp;</strong>They <strong>reduce</strong> both <strong>syncope</strong> and <strong>sudden cardiac death</strong> (SCD).</p>\n<p>Long QT syndrome (LQTS) is a <strong>disorder</strong> of <strong>ventricular myocardial repolarization</strong> characterized by a prolonged QT interval on the electrocardiogram that can lead to symptomatic <strong>ventricular arrhythmias</strong> and an increased risk of sudden cardiac death.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3110",
      "difficulty": "medium"
    },
    {
      "text": "An elderly patient with heart failure and atrial fibrillation is stabilized with digoxin. By what mechanism does it control the arrhythmia in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vagolytic action"
        },
        {
          "id": 2,
          "text": "Sympatholytic action"
        },
        {
          "id": 3,
          "text": "Increasing vagal tone"
        },
        {
          "id": 4,
          "text": "Decreasing atrial repolarization by blocking Na+ channels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong> Digoxin </strong>results in&nbsp;an<strong> increased vagal tone </strong>which helps in <strong>controlling</strong> the <strong>ventricular rate</strong> in atrial fibrillation.</p>\n<p>Increased vagal tone increases the AV nodal refractoriness due to blockade of Ca<sup>2+</sup> channels. It also results in hyperpolarisation and shortening of atrial action potentials due to activation of ACh-mediated K<sup>+</sup> channels in the atria.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3108",
      "difficulty": "medium"
    },
    {
      "text": "A male patient who is suffering from a psychotic disorder is on antipsychotic, antidepressant and antihypertensive treatment. He suddenly developed tachycardia and chest tightness. On evaluation he had metabolic acidosis. ECG showed widened QRS complex and prolonged QT interval. Which of the following drugs is responsible for this?",
      "choices": [
        {
          "id": 1,
          "text": "Amitriptyline"
        },
        {
          "id": 2,
          "text": "Amlodipine"
        },
        {
          "id": 3,
          "text": "Chlorthalidone"
        },
        {
          "id": 4,
          "text": "Enalapril"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>torsades de pointes. </strong>Only <strong>amitriptyline</strong> causes this condition, among the above drugs.</p>\n<p><strong>Torsades de pointes</strong> (French: twisting of points) is a life-threatening form of <strong>polymorphic ventricular tachycardia</strong> with rapid asynchronous complexes and an <strong>undulating baseline on ECG.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/535a12eac6994d8da51548e737760d35x1268x324.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Drugs causing QT prolongation and torsades de pointes</h3><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br />&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9517",
      "difficulty": "medium"
    }
  ]
}